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Background:  Monitoring of anesthetic depth is important for successful general anesthesia. It is well known that 
entropy or BIS monitoring assisted titration of anesthetic drugs decreases their consumption. This study evaluated 
the effect of remifentanil on consumption of sevoflurane during entropy monitored general anesthesia. 
Methods:  Patients were randomly assigned to two groups. The R group was administered 0.1 μg/kg/min of 
remifentanil and inhaled sevoflurane, while the S group was administered only inhaled sevoflurane. Anesthesia was 
maintained using sevoflurane with nitrous oxide, and entropy was monitored. In both groups, the concentration of 
sevoflurane was adjusted to keep the state entropy (SE) value between 40 and 60. End-tidal sevoflurane concentration 
(ET), entropy value, systolic blood pressure (SBP), diastolic blood pressure (DBP) and heart rate (HR) were measured 
at 5 minute intervals, during a 25 minute period after intubation, skin suture and the end of surgery.
Results:  ET was significantly lower in the R group than the S group. There were no significant differences in entropy 
value between R and S groups. 
Conclusions:  Entropy monitored titration of sevoflurane with remifentanil administration decreased ET with stable 
hemodynamics. (Korean J Anesthesiol 2010; 59: 238-243)
Key Words:  Entropy, Remifentanil, Sevoflurane.
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Introduction
    Anesthetic awareness can cause perioperative pain and 
discomfort, as well as temporary after-effects, such as 
postoperative anxiety, sleep disorder, nightmares, and recall. 
In some cases, it can cause post-traumatic stress disorder. 
Therefore, the anesthesiologist has to carefully maintain 
anesthetic depth. 
    Anesthetic depth is judged from observing vital signs and can 
be adjusted by the dose of administered anesthetics, depending 
on the patient’s vital signs. Monitoring anesthetic depth makes 
it possible to administer the appropriate dose of anesthetics 
and prevent anesthetic awareness, side-effects of over-dose, 
and economic and environmental waste. Therefore, anesthetic 239 www.ekja.org
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management, using proper anesthetic administration, is equally 
important as maintaining the patient’s vital signs. 
    Entropy monitoring allows for the quantification of cerebral 
neural activity. The increase and decrease in entropy scores are 
related to the level of consciousness under anesthesia. EEG-
entropy is an entropy monitor based on EEG analysis used in 
measuring hypnosis levels [1]. EEG-entropy has two signals: 
State entropy (SE) receives information from the brain waves; 
response entropy (RE) incorporates information from the 
frontal eletromyography. SE is computed using EEG data 
from the previous 15 s, between 0.8-32 Hz, and shows the 
value in the range of 0-91. RE is computed from 32-47 Hz 
with 1.92 s, and reflects fast muscular activity from the frontal 
muscle, and shows the value in the range of 0-100. Similar 
to BIS, 100 signifies awake; 60, clinically significant anesthetic 
state; 40, low possibility of consciousness; and 0, suppression of 
cortical activity [2]. 
    The authors maintained the appropriate anesthetic depth for 
patients undergoing entropy-monitored gynecological surgery 
and controlled anesthetic depth by titrating the concentration 
of the inhaled anesthetic - sevoflurane. In this study, the authors 
attempted to compare the ET sevoflurane concentration (ET) 
when using continuous infusion of sevoflurane alone, against 
ET when using remifentanil as a supplement to sevoflurane, to 
determine the difference in administered doses of sevoflurane. 
Materials and Methods 
    Upon receiving the approval of the hospital ethics committee 
and the consent of the patients after they were informed 
about the study during preanesthetic visitation, we performed 
the study on 40 patients of ASA class I & II, electing for 
gynecological surgery under general anesthesia.
    Patients were excluded if they had a neurologic or psychiatric 
disease, past history of cardiovascular disease, or if they had 
consumed sedatives, antidepressants, anticonvulsants, or 
opioids. Also, patients were excluded if intubation was expected 
to be difficult or had been difficult in the past. 
    The patients were randomly divided into two groups that were 
infused with remifentanil (Group R) or normal saline (Group 
S). Normal saline (40 ml) and remifentanil (40 ml) diluted with 
normal saline (50 μg/ml) were prepared in continuous infusors. 
The anesthesiologist was blinded for the study and no patient 
was given premedication. Upon arrival onto the operating table, 
electrocardiography, non-invasive blood pressure, and pulse 
oxymetry were attached for monitoring. The entropy sensor was 
attached to the patient’s forehead (Entropy Sensor, Disposable, 
GE Healthcare, Helsinki, Finland), connecting the patient to 
the entropy monitor (S/5 Entropy Module, Datex-Ohmeda, 
Madison, WI, USA).
    Anesthesia was induced using thiopental sodium (5 mg/kg) 
in both groups. After loss of consciousness, rocuronium (1.0 
mg/kg) was administered, and manual mask ventilation was 
performed using 4 vol% sevoflurane. After sufficient muscle 
relaxation, before intubation, IV remifentanil (1.0 μg/kg) 
was slowly administered for 1 min in both groups. Following 
intubation, O2-N2O-sevoflurane was used for the maintenance 
of anesthesia. In the two groups, either the prepared normal 
saline or remifentanil was administered with the continuous 
infusor at the rate of 0.002 ml/kg/min, 2 vol% sevoflurane 
was inhaled, and the SE value was maintained between 40-
60 by titrating 0.5 vol% sevoflurane every 5 minutes. Despite 
controlling the concentration of sevoflurane to maintain 
SE value, when the hemodynamics could not be stabilized, 
cardiovascular drugs were used and recorded afterwards. The 
surgery proceeded, and when skin suturing (SS) was started, 
the continuous infusion of either saline solution or remifentanil 
and the administration of sevoflurane were stopped and the 
patient was ventilated with 100% O2. After the surgery, muscle 
relaxation was reversed.
    The systolic blood pressure (SBP), diastolic blood pressure 
(DBP), heart rate (HR), RE, SE, and end-tidal sevoflurane 
concentration (ET) measurements were recorded by a blinded 
medical resident immediately after intubation, at 5 min 
intervals over a 25 min period, at the beginning of SS and at 
the end of surgery. The measurements of the two groups were 
compared. The mean ET scores taken every 5 min immediately 
after intubation until the end of surgery were averaged and 
analyzed for the purpose of comparing sevoflurane. 
     All statistical analyses were performed on SPSS (version 18.0, 
SPSS Inc., IL, USA). The values were expressed as mean ± SD. 
To test homogeneity, age height, weight and the administration 
time of sevoflurane were analyzed using an independent t-test 
and ASA classes using a chi-square test. The comparison of the 
mean ET measured from post-intubation until the end of the 
surgery for the two groups was analyzed using an independent 
t-test. ET, RE, SE, SBP, DBP, and HR values were analyzed using 
a repeated measure one-way ANOVA. When time affected a 
line, a contrast test was performed on the values taken 5 min 
post-intubation to the end of surgery. The analysis of each 
period was done using an independent t-test; P < 0.05 was 
considered statistically significant.
Results
    The demographic data analysis showed no statistical 
differences in the patient age, weight, or height (Table 1). The 
two groups showed significant differences in ET (Fig. 1) (P < 
0.05). During time periods from 5 min post-intubation to the 
end of surgery, ET values were significantly lower in Group R 240 www.ekja.org
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compared to Group S (Fig. 1) (P < 0.05). Perioperative mean ET 
in Group S (1.63 ± 0.15) was significantly lower than in Group R 
(1.11 ± 0.10) (P < 0.05).
    RE and SE were maintained in both groups between 40-60, 
and there were no significant differences amongs subjects in 
both groups (Fig. 2 and 3) (P > 0.05).
    The SBP and DBP were not significantly different and they 
were similar with the progress of time (P > 0.05). Comparing 
intervals, Group R compared to Group S had low SBP and 
DBP 10 min and 15 min post-intubation, but there were 
no differences afterwards (Fig. 4 and 5). HR values were 
Table 1. Demographic Data
Group S
(n = 20)
Group R
(n = 20)
P value
Age (yr)
Weight (kg)
Height (cm)
Sevoflurane time (min)
ASA class (1/2)
43.00 ± 12.14
58.75 ± 7.81
158.45 ± 5.13
73.25 ± 22.90
16/4
43.90 ± 8.45
57.80 ± 7.36
156.05 ± 5.60
76.25 ± 23.89
16/4
 0.787*
 0.694*
 0.165*
 0.687*
 1.000
†
Values are expressed as mean ± SD. Group S: group received normal 
saline. Group R: group received remifentanil (0.1 μg/kg/min). There 
were no significant differences among the groups. *Independent 
t-test, 
†Chi-Square test.
Fig. 1. Change of end-tidal sevoflurane concentration. Values are 
expressed as mean ± SD. Group S: group received normal saline. 
Group R: group received remifentanil (0.1 μg/kg/min). ET0-25: end-
tidal sevoflurane concentration at 0-25 minute after intubation, 
ETss: end-tidal sevoflurane concentration at skin suture, ETend: 
end-tidal sevoflurane concentration at end of surgery. *P < 0.05 
compared with ET0. 
†P < 0.05 compared with Group S.
Fig. 2. Change of response entropy. Values are expressed as mean ± 
SD. Group S: group received normal saline. Group R: group received 
remifentanil (0.1 μg/kg/min). RE0-25: response entropy at 0-25 
minute after intubation, REss: response entropy at skin suture, 
REend: response entropy at end of surgery. 
Fig. 3. Change of state entropy. Values are expressed as mean ± SD. 
Group S: group received normal saline. Group R: group received 
remifentanil (0.1 μg/kg/min). SE0-25: state entropy at 0-25 minute 
after intubation, SEss: state entropy at skin suture, SEend: state 
entropy at end of surgery. 
Fig. 4. Change of systolic blood pressure. Values are expressed as 
mean ± SD. Group S: group received normal saline. Group R: group 
received remifentanil (0.1 μg/kg/min). SBP0-25: systolic blood 
pressure at 0-25 minute after intubation, SBPss: systolic blood 
pressure at skin suture, SBPend: systolic blood pressure at end of 
surgery. *P < 0.05 compared with SBP0. 
†P < 0.05 compared with 
Group S.241 www.ekja.org
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significantly different (P < 0.05). Although Group R, compared 
to Group S, had lower HR values from 10 min post-intubation 
(Fig. 6) (P < 0.05), this was clinically insignificant. Neither group 
required drug administration for intra-operative hemodynamic 
stabilization.
Discussion
    In general anesthesia, correctly judging and maintaining 
anesthetic depth is very important. Judging the depth of 
anesthesia from observing patient cardiovascular response 
and then titrating the dose of anesthetics is common, but with 
the introduction of EEG-entropy, one can monitor the depth of 
anesthesia and the hypnosis level, and it measures anesthetic 
depth similar to BIS in anesthesia using propofol or sevoflurane 
[1-4].
    Vakkuri et al. [2] stated that in sevoflurane-anesthesia, the 
appropriate depth of anesthesia has the entropy value of 40-60. 
In the current study, sevoflurane concentration was adjusted 
so the entropy value could be maintained between 40-60. 
Comparisons of RE and SE between the two groups showed no 
significant differences, and they followed similar changes with 
time. 
    Remifentanil is an opioid, with a rapid onset of effect and 
a short duration that selectively affects the μ-receptor [5]. 
Because of its pharmacokinetic characteristics, it is commonly 
used as a supplement in general anesthesia performed with 
inhaled or intravenous anesthetics [6]. However, it has side-
effects such as hypotension, postoperative nausea and vomiting 
(PONV), respiratory depression, and increased postoperative 
pain. O’Hare et al. [7] stated that a bolus infusion of remifentanil 
(1 μg/kg) can control the balance of hemodynamic response 
at the time of intubation and reduce the risk of post-intubation 
hypotension. Lee et al. [8] stated that a bolus infusion of 
remifentanil (1.0 or 2.0 μg/kg) effectively suppresses the 
increase in post-intubation mean arterial blood pressure 
(MAP) and HR. A remifentanil dose of 2.0 μg/kg can permit 
hypotension to persist, so 1.0 μg/kg is considered the more 
appropriate dose. Song and White [9] stated that in desflurane-
anesthesia, a low supplementary dose of remifentanil (0.07 
μg/kg/min) can effectively control the autonomic nervous 
system response to nociceptive stimulation during laparoscopic 
surgery, and allows for fast awakening without postoperative 
side-effects. Song et al. [10] compared the usage to the non-
usage of remifentanil (0.05-0.2 μg/kg/min) in patients under 
sevoflurane-anesthesia for a laparoscopic cholecystectomy and 
found that the patient awakening and extubation times were 
shorter without raising PONV rates and without the extra use of 
antiemetics or analgesics. 
    Lee et al. [11] also similarly found that patients undergoing 
laparoscopic cholecystectomy, who were anesthetized with 
sevoflurane with the continuous infusion of remifentanil 
(0.1 μg/kg/min), did not have higher rates of PONV, pain, 
or a greater use of analgesics. Calderón et al. [12] found that 
when either remifentanil (0.05 μg/kg/min or 0.1 μg/kg/min) 
was continuously infused in patients undergoing elective 
abdominal and thoracic surgery, postoperative pain was 
effectively managed in both groups, without side-effects such as 
respiratory depression or PONV. Also, the group continuously 
infused with remifentanil (0.1 μg/kg/min) required less 
Fig. 5. Change of diastolic blood pressure. Values are expressed as 
mean ± SD. Group S: group received normal saline. Group R: group 
received remifentanil (0.1 μg/kg/min). DBP0-25: diastolic blood 
pressure at 0-25 minute after intubation, DBPss: diastolic blood 
pressure at skin suture, DBPend: diastolic blood pressure at end of 
surgery. *P < 0.05 compared with DBP0. 
†P < 0.05 compared with 
Group S.
Fig. 6. Change of heart rate. Values are expressed as mean ± SD. 
Group S: group received normal saline. Group R: group received 
remifentanil (0.1 μg/kg/min). HR0-25: heart rate at 0-25 minute 
after intubation, HRss: heart rate at skin suture, HRend: heart rate at 
end of surgery. *P < 0.05 compared with HR0. 
†P < 0.05 compared 
with Group S.242 www.ekja.org
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additional analgesics. Therefore, the current study sought to 
stabilize hemodynamic response to intubation while reducing 
the risk of post-intubation hypotension by slowly infusing IV 
remifentanil (1.0 μg/kg) for 1 min. To effectively control post-
intubation perioperative autonomic nervous system response 
and to allow for faster awakening without side-effects, a low 
dose of remifentanil (0.1 μg/kg/min) was continuously infused. 
The vital signs were then measured, and showed that they were 
lower for Group R than Group S. Neither group required drugs 
to safely maintain hemodynamics. 
    Gómez de Segura et al. [13] found through a rat experiment, 
that the continuous infusion of remifentanil in rats under 
sevoflurane-anesthesia decreased sevoflurane MAC proportio-
nally to the dose of remifentanil. Manyam et al. [14] found that 
remifentanil decreased the required dose of sevoflurane when 
they performed anesthesia using TCI of sevoflurane (0.3-6 
vol%) and the effect-site concentration of remifentanil was 0.5-
15 ng/ml. Pavlin et al. [15] used a BIS monitor to titrate the dose 
of sevoflurane and found that ET was reduced by 13%. Aimé 
et al. [16] found that in sevoflurane-anesthesia using either 
BIS or an entropy monitor to titrate the administered dose of 
anesthetics, both monitoring methods equally reduced the 
administered dose of sevoflurane by 29%. 
    Therefore, the current study used an entropy monitored 
titration of sevoflurane and the continuous infusion of remi-
fentanil to determine if the administered dose of sevoflurane 
could be reduced, and the results were significantly different. 
Compared to Group S, Group R had significantly lower ET, and 
significantly lower mean ET when measured during surgery. 
When sevoflurane alone is used in anesthesia, compared to 
when remifentanil is used as a supplement, it is believed that a 
greater dose of sevoflurane is unnecessary. 
    Many factors affect the patient’s recovery from anesthesia, 
and the level of the residual anesthetic can be a factor. Also, 
if an individual’s methabolism rate of the drug is consistent, 
the determinant factor is the administered dose of the 
anesthetic. Recart et al. [17] studied 90 patients to determine 
the effect of desflurane dose on the recovery time. Patients 
who were administered low doses of desflurane, from titrating 
to the auditory evoked potential or BIS monitor, had shorter 
extubation times and shorter lengths of PACU stay. Thus, the 
dose of anesthetics was found to directly affect recovery rates. 
Also, many studies have found that compared to the single 
use of sevoflurane, the combined use of remifentanil and 
sevoflurane reduces the required dose of sevoflurane and 
allows for faster patient recovery [18,19]. Although the current 
study did not measure the extubation or recovery times, the 
authors found that the continuous infusion of remifentanil 
proved to reduce the necessary dose of sevoflurane, and may 
also help in the recovery from anesthesia. 
    The current study monitored the depth of anesthesia when 
sevoflurane alone and when sevoflurane plus a low dose of 
remifentanil (0.1 μg/kg/min) were administered; and the 
authors found that with the combined use of remifentanil, low 
doses of sevoflurane can also maintain anesthetic depth. The 
intra-operative mean ET was reduced approximately 32%. In 
the combined use of sevoflurane and remifentanil, the authors 
kept the dose concentration consistently at 0.1 μg/kg/min, but 
titrating remifentanil’s concentration to hemodynamic changes 
may also be helpful.
    In conclusion, in entropy monitoring of anesthetic depth, 
administering a low dose of remifentanil (0.1 μg/kg/min) as a 
supplement to inhaled anesthetics, will allow for a decreased 
dose of inhaled anesthetics, compared to when inhaled 
anesthetics are used alone. This will prevent the delay in 
recovery resulting from overdose and circumvent economic and 
environmental waste. Even without the entropy-monitoring 
of anesthetic depth, the combined use of sevoflurane and 
remifentanil can reduce the inhaled dose of sevoflurane, 
without perioperative awareness. 
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